MARKET

ADAG

ADAG

Adagene Inc.
NASDAQ
3.400
+0.090
+2.72%
After Hours: 3.340 -0.06 -1.76% 19:30 09/11 EDT
OPEN
3.360
PREV CLOSE
3.310
HIGH
3.480
LOW
3.239
VOLUME
258.87K
TURNOVER
--
52 WEEK HIGH
4.850
52 WEEK LOW
1.300
MARKET CAP
228.29M
P/E (TTM)
-9.0258
1D
5D
1M
3M
1Y
5Y
1D
Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)
TipRanks · 1d ago
Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8
TipRanks · 2d ago
Adagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected
TipRanks · 2d ago
Third Arc Bio Selects First Lead Candidate Upon 2025 Amended Strategic License Deal With Adagene
Benzinga · 2d ago
Adagene Price Target Announced at $9.00/Share by Chardan Capital
Dow Jones · 2d ago
Adagene Initiated at Buy by Chardan Capital
Dow Jones · 2d ago
Chardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9
Benzinga · 2d ago
Adagene initiated with a Buy at Chardan
TipRanks · 2d ago
More
About ADAG
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.

Webull offers Adagene Inc (ADR) stock information, including NASDAQ: ADAG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADAG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADAG stock methods without spending real money on the virtual paper trading platform.